A special helicobacter pylori resistance detection kit developed by Cwbio IT Group, located in the Taizhou Medical High-tech Zone in Taizhou city, East China's Jiangsu province, recently got an important green light.
It recently obtained a Class III medical device registration certificate, approved by the National Medical Products Administration.
The product adopts a fluorescence PCR method, which can assist clinical doctors in developing personalized eradication plans, thereby improving eradication rates and achieving primary prevention of gastric cancer.
At present, the main method used for detecting helicobacter pylori resistance in clinical practice is the culture drug sensitivity method.
However, its clinical application is limited due to factors such as complex operations, high requirements for technical personnel and a long detection cycle.
Cwbio IT Group's product adopts molecular detection technology, with high detection sensitivity and short detection cycle. This can provide a timely reference for clinical doctors to choose sensitive antibiotics.
Cwbio IT Group is mainly engaged in the research and production of high value-added and high-tech biological reagents, offering innovative biological products and services for global life science research, genetic testing and in vitro diagnostics users.
The group is committed to becoming a one-stop solution provider integrating the research and development, production and sales of molecular diagnostic reagents and their raw materials, as well as third-party medical testing services.
The sleek exterior of the premises of Cwbio IT Group. [Photo/cmc.gov.cn]